MGMT and oligodendroglial tumor: Special emphasis will be put on the introduction of those molecular biomarkers that have been established in glioma diagnostics, namely MGMT promoter hypermethylation in glioblastomas and deletion of chromosome arms 1p and 19q in patients with oligodendroglial tumors.